The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Midatech Pharma up 90% on Q-Sphera breakthrough

Thu, 17th Jun 2021 11:43

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Midatech Pharma PLC, up 89% at 51.90 pence, 12-month range 18.10p-87.00p. The biotechnology company says it has data demonstrating that its Q-Sphera technology can formulate monoclonal antibodies into long-acting injectables, a novel development in pharmaceuticals with significant medical and commercial potential. "The company believes no other commercial or academic organisation has been able to successfully deliver therapeutic proteins over extended periods using methods capable of commercial scaling," it says.

----------

Blue Prism Group PLC, up 7.4% at 964.50p, 12-month range 883.50p-1,900.00p. The robotic process automation firm posts narrowed interim loss after seeing growing revenue and booking numbers for the period. Blue Prism reports a pretax loss of GBP21.0 million for the six months ended April 30, sharply narrowed from GBP53.8 million a year prior. Bookings grew 35% in the first half to GBP98 million, or 39% at constant currency. Revenue for the period increased by 21% year-on-year to GBP80.4 million from GBP66.6 million, with recurring, subscription-based, licence revenue accounting for a 98% share.

----------

AIM - LOSERS

----------

Open Orphan PLC, down 14% at 30.00p, 12-month range 11.16p-34.50p. The pharmaceutical services company posts 2020 pretax loss GBP11.2 million, widened from GBP5.8 million on revenue from continuing operations of GBP20.6 million, up from GBP3.4 million. Separately, Poolbeg Pharma confirms plan to float on AIM as a spinoff of Open Orphan. Poolbeg Pharma to use IPO raise to fund clinical trial of treatment for severe influenza.

----------

Cake Box Holdings PLC, down 7.3% at 266.50p, 12-month range 155.00p-356.00p. The eggless deserts maker notes movement in shares. It confirms that it has recently emailed customers in relation to a data breach experienced in 2020 as a result of which personal and financial information may potentially have been accessed. Cake Box says it has taken the appropriate steps to investigate the incident, repair the compromised systems, and identify those customers that may have been compromised. It also has further strengthened the security of its systems to prevent future breaches, it says. "The company confirms that the data breach is not expected to have a material financial impact and as per the announcement on 12 April 2021, full year results are expected to be in line with market expectations," Cake Box adds.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 Nov 2021 11:32

Open Orphan subsidiary secures contract renewal with 'major' pharmaceutical client

(Sharecast News) - Contract research organisation Open Orphan said on Monday that its Venn Life Sciences subsidiary had signed a contract renewal with an unnamed "major global pharmaceutical client" worth £1.5m over a two-year period.

Read more
13 Oct 2021 13:25

EXECUTIVE CHANGES: Halfords hires CFO; new Pendragon, Versarien chairs

EXECUTIVE CHANGES: Halfords hires CFO; new Pendragon, Versarien chairs

Read more
20 Sep 2021 14:30

Open Orphan signs £5.7m contract with biotech specialist

(Sharecast News) - Clinical research organisation Open Orphan announced on Monday that its subsidiary hVIVO has signed a £5.7m contract with a specialist biotechnology company developing therapeutics for respiratory viral infections, to test its antiviral product using the hVIVO Influenza human challenge study model.

Read more
20 Sep 2021 12:02

TRADING UPDATES: Christie Group and Open Orphan swing to profit

TRADING UPDATES: Christie Group and Open Orphan swing to profit

Read more
13 Sep 2021 16:11

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
7 Sep 2021 18:16

TRADING UPDATES: Victoria growth continues; Renew to beat consensus

TRADING UPDATES: Victoria growth continues; Renew to beat consensus

Read more
7 Sep 2021 14:59

TRADING UPDATES: Marlowe buys Santia; Gaming Realms notes new launch

TRADING UPDATES: Marlowe buys Santia; Gaming Realms notes new launch

Read more
24 Aug 2021 11:41

AIM WINNERS & LOSERS: Open Orphan rises on asthma study contract win

AIM WINNERS & LOSERS: Open Orphan rises on asthma study contract win

Read more
24 Aug 2021 09:31

Open Orphan shares lift on GBP8.1 million asthma study contract win

Open Orphan shares lift on GBP8.1 million asthma study contract win

Read more
9 Aug 2021 17:08

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

Read more
22 Jul 2021 10:49

AIM WINNERS & LOSERS: Restore rises as it rebuffs Marlowe approach

AIM WINNERS & LOSERS: Restore rises as it rebuffs Marlowe approach

Read more
14 Jul 2021 16:15

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
14 Jul 2021 15:07

IN BRIEF: Open Orphan study grows, spinoff worth GBP50 million at IPO

IN BRIEF: Open Orphan study grows, spinoff worth GBP50 million at IPO

Read more
14 Jul 2021 15:01

IN BRIEF: Open Orphan team invests GBP350,000 as spin-off set to debut

IN BRIEF: Open Orphan team invests GBP350,000 as spin-off set to debut

Read more
14 Jul 2021 09:10

Open Orphan secures €900,000 contract with existing customer

(Sharecast News) - Pharmaceutical services company Open Orphan has secured a new contract win with an unnamed existing customer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.